MS & Immune Disorders

Filter Your Results

 

News

 

Ocrelizumab Delays Cognitive Decline and Reduces Disease Activity and Disability Progression in Patients With MS

Wednesday, April 25, 2018—New data on ocrelizumab (OCREVUS; Genentech, South San Francisco, CA) were presented at the American Academy of Neurology this week, including results from 4 years of continuo…

New AAN Guideline: Patients With Multiple Sclerosis Should Start Treatment Early

Monday, April 23, 2018—The American Academy of Neurology (AAN) has released a new guideline for treating patients with multiple sclerosis (MS), which is endorsed by both the National Multiple Sclero…

New Data on Ocrelizumab

Monday, April 16, 2018—Researchers will be presenting, at the upcoming American Academy of Neurology (AAN) meeting beginning on April 21st, 2018, new data on the use of ocrelizumab (OCREVUS; Genente…

Phase 3 Clinical Trial Shows Siponimod Significantly Improved Outcomes in Patients With Secondary Progressive Multiple Sclerosis

Thursday, March 22, 2018—Results from the phase 3 clinical trial, EXPAND, studying oral, once-daily siponimod (Novartis; East Hanover, NJ) for treatment of secondary progressive multiple sclerosis (SP…

Subcutaneous Immune Globulin Approved for Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Friday, March 16, 2018—Already approved in 51 countries for some immune deficiencies, subcutaneous immune globulin (IG) (Hizentra; King of Prussia, PA) has now been approved by the Food and Drug Adm…

Consuming Fish and/or Omega-3 Fatty Acids 1-3 Times Per Week May Decrease Risk of Multiple Sclerosis

Friday, March 02, 2018—A preliminary study funded by the National Institute of Neurologic Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), shows that there is a corre…

Multiple Sclerosis Association of America Kicks Off Understanding Multiple Sclerosis Progression Campaign for Multiple Sclerosis Awareness Month

Thursday, March 01, 2018—For multiple sclerosis (MS) Awareness Month, the Multiple Sclerosis Association of America (MSAA) focuses on their campaign on Understanding MS Progression…

Microglia May Promote Recovery of Motor Neurons in Amyotrophic Lateral Sclerosis

Wednesday, February 21, 2018—In findings published this week in Nature Neuroscience, researchers Krista J. Spiller, Clark R. Restrepo, Tahiyana Khan, and others described creation of a mouse model of amyo…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC